AstraZeneca leaves door ajar to Pfizer, despite hurdles

[riky]

AstraZeneca leaves door ajar to Pfizer, despite hurdles

<p><a href="http://news.yahoo.com/astrazeneca-leaves-door-ajar-pfizer-despite-hurdles-213630346--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/5TVHUFPNzvRf5Aj7ZvFPow--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-05-14T213630Z_1_LYNXMPEA4D0RJ_RTROPTP_2_ASTRAZENECA-PFIZER.JPG" width="130" height="86" alt="Chief Executive of AstraZeneca Pascal Soriot leaves after appearing at a commons science committee hearing at Portcullis House in London" align="left" title="Chief Executive of AstraZeneca Pascal Soriot leaves after appearing at a commons science committee hearing at Portcullis House in London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - AstraZeneca's boss said on Wednesday he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's operations into the U.S. company's new three-unit model were addressed. Chief Executive Pascal Soriot stressed his company had a bright future as a stand-alone firm but acknowledged that shareholders would expect AstraZeneca's board to negotiate if terms were sufficiently attractive in a sweetened offer.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login